Hypothesis

In aged, obese adipose tissue, senescent fibroblasts develop a mechanosensitive state characterized by elevated lamin A/C expression that suppresses matrix metalloproteinase (MMP) activity and promotes tissue inhibitor of metalloproteinases (TIMP) secretion, thereby sustaining fibrosis despite the systemic MMP‑rich environment of aged skin.

Mechanistic Rationale

• Hypoxia‑induced cytoskeletal tension activates integrin‑FAK signaling, driving nuclear translocation of YAP/TAZ and upregulating lamin A/C (see hypoxia‑driven ECM synthesis)[1].
• Elevated lamin A/C stiffens the nucleus, impairing chromatin accessibility at MMP gene promoters and enhancing TIMP‑1 transcription via SRF‑dependent pathways.
• This creates a MMP/TIMP imbalance that favors net collagen deposition, mirroring the MMP suppression observed in obese adipose tissue[2] while aged dermal fibroblasts constitutively express MMPs[4].
• Senescent fibroblast phenotype: young senescent cells retain regenerative programs[6]; with aging, lamin A/C–mediated mechanotransduction shifts them toward a pro‑fibrotic, TIMP‑high state, explaining the coexistence of inflammatory signaling and MMP suppression in aged, obese adipose tissue.
• PAI‑1 amplification: lamin A/C–dependent TGF‑β signaling further induces PAI‑1, a hallmark of adipose aging[5], reinforcing fibrosis.

Testable Predictions

1. Lamin A/C levels will be significantly higher in fibroblasts isolated from aged, obese mice compared with young lean, aged lean, or young obese controls.
2. Knockdown of lamin A/C (siRNA or CRISPRi) in aged‑obese fibroblasts will restore MMP‑2/9 activity, reduce TIMP‑1 secretion, and decrease collagen I/III deposition in 3D culture.
3. Pharmacological inhibition of integrin‑FAK (e.g., PF‑573228) will blunt lamin A/C upregulation and rescue MMP expression under hypoxic conditions.
4. In vivo, adipocyte‑specific overexpression of lamin A/C in mice will exacerbate adipose fibrosis and insulin resistance upon high‑fat diet, whereas fibroblast‑specific lamin A/C deletion will protect against fibrosis despite obesity and aging.

Experimental Approaches

• Isolate stromal vascular fraction (SVF) from epididymal fat of young (3 mo) and aged (18 mo) mice fed chow or high‑fat diet for 12 weeks; fibroblast enrichment via PDGFRα^+ sorting.
• Measure lamin A/C by Western blot and immunofluorescence; assess nuclear shape via DAPI staining.
• Quantify MMP‑2, MMP‑9, TIMP‑1, TIMP‑2 mRNA (qPCR) and activity (gelatin zymography).
• Treat cultures with hypoxic chamber (1% O₂) ± FAK inhibitor; evaluate lamin A/C and MMP/TIMP readouts.
• Perform siRNA-mediated lamin A/C knockdown; assess collagen gel contraction and hydroxyproline content.
• In vivo validation using fibroblast‑specific Col1a2‑CreERT2; Lmna^fl/fl mice subjected to HFD and aging; endpoint histology (Picrosirius Red), metabolic assays (GTT, ITT), and adipose macrophage flow cytometry.

Falsifiability

If lamin A/C expression does not differ between conditions, or its manipulation fails to alter MMP/TIMP balance and fibrosis outcomes, the hypothesis would be refuted, indicating that other mechanisms dominate the age‑obesity fibrotic phenotype.

This framework integrates hypoxia‑driven mechanotransduction, nuclear lamina remodeling, and senescence biology to explain why adipose tissue becomes progressively fibrotic with age and obesity, offering a concrete node for therapeutic intervention.